Could your daily routine lead to dementia? New research points to sedentary lifestyle as potential risk factor

In a recent study, researchers investigated whether accelerometer-assessed sedentary behavior was associated with incident dementia.

Transforming Shots Into Pills; ‘Tip of the Iceberg’ for TILs? Food Additives Warning

A California startup has the lofty goal of transforming blockbuster injectable and infusional drugs into pills. (Endpoints News) Johnson & Johnson announced FDA approval of

February 24, 2024

Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024 | Psychedelic Invest

VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical

April 24, 2024

Why Eli Lilly’s earnings didn’t quite live up to the hype

Eventually, the luckiest companies get to deal with a very particular problem: what to do when their stock could be getting ahead of itself. It’s

February 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.